WHO Target Product Profiles for mpox vaccines
This above document describes the preferred and minimally acceptable profiles for human vaccines for mpox. All vaccines considered for use must meet appropriate regulatory standards. In general, the minimally acceptable profiles are aligned with expectations for emergency use listing of new vaccines. Licensed or pre-qualified vaccines would likely have more of the attributes of the preferred profile.
You are invited to participate and we welcome your expert input. Please submit comments to the rdblueprint@who.int email by Friday 23 August, 17:00 CEST.